Exemestane (commonly known by the brand name Aromasin)
is an oral
aromatase inhibitor. It is primarily prescribed to
postmenopausal women to treat hormone receptor-positive early or advanced
breast cancer, and to prevent the cancer from returning after initial
treatments such as surgery or tamoxifen therapy.
